Search research articles
Contact Us
Filters
Showing results (111-120 of 349) with videos related to
Page
of 35
Sort By:
JAMA Cardiology
|
September 21, 2022
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled
João Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Journal of the American College of Cardiology
|
April 3, 2010
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data
Keith A A Fox, Tim C Clayton, Peter Damman, et al.
Circulation
|
August 25, 2023
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
Milton Packer, Javed Butler, Cordula Zeller, et al.
European Journal of Heart Failure
|
May 23, 2022
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions
Stefan D Anker, Tariq Jamal Siddiqi, Gerasimos Filippatos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 29, 2018
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
Xavier Rossello, Cono Ariti, Stuart J Pocock, et al.
European Heart Journal
|
June 10, 2022
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
João Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Journal of the American College of Cardiology
|
September 14, 2019
In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non-ST-Segment Elevation Acute Coronary Syndrome
Héctor Bueno, Xavier Rossello, Stuart J Pocock, et al.
European Heart Journal
|
February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
Michel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.
International Journal of Surgery (London, England)
|
July 22, 2014
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
Jan P Vandenbroucke, Erik von Elm, Douglas G Altman, et al.
JAMA
|
May 3, 2007
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial
Alexandre Mebazaa, Markku S Nieminen, Milton Packer, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 349) with videos related to
Sort By:
Page
of 35
JAMA Cardiology
|
September 21, 2022
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled
João Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Journal of the American College of Cardiology
|
April 3, 2010
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data
Keith A A Fox, Tim C Clayton, Peter Damman, et al.
Circulation
|
August 25, 2023
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
Milton Packer, Javed Butler, Cordula Zeller, et al.
European Journal of Heart Failure
|
May 23, 2022
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions
Stefan D Anker, Tariq Jamal Siddiqi, Gerasimos Filippatos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
September 29, 2018
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
Xavier Rossello, Cono Ariti, Stuart J Pocock, et al.
European Heart Journal
|
June 10, 2022
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
João Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Journal of the American College of Cardiology
|
September 14, 2019
In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non-ST-Segment Elevation Acute Coronary Syndrome
Héctor Bueno, Xavier Rossello, Stuart J Pocock, et al.
European Heart Journal
|
February 2, 2010
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
Michel Komajda, John J V McMurray, Henning Beck-Nielsen, et al.
International Journal of Surgery (London, England)
|
July 22, 2014
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
Jan P Vandenbroucke, Erik von Elm, Douglas G Altman, et al.
JAMA
|
May 3, 2007
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial
Alexandre Mebazaa, Markku S Nieminen, Milton Packer, et al.
Page
of 35